Time
7:30am –
2:00pm
1:00pm
1:00pm
2:00pm 3:30pm
3:30pm –
4:30pm
4:30pm6:00pm
Wednesday October 15, 2014
Presentation Title/Event
Board Meeting
Registration Opens
Exhibitor Set Up Begins
PSHP Update and Healthcare Impact on Pharmacy Services
Pharmacist Objectives:
1. Discuss the current topics pertaining to PSHP.
2. Identify and discuss the current healthcare environment and
its effects on services that pharmacists provide.
Technician Objectives:
1. Discuss the current topics pertaining to PSHP.
2. Discuss the impact that the current healthcare environment
has on the duties and responsibilities of pharmacy technicians.
Implementation of a Specialty Pharmacy
Pharmacist Objectives:
1. What are important roles for Pharmacists within Specialty
Pharmacy?
Technician Objectives:
2. What are unique roles for Pharmacy Technicians within
Specialty Pharmacy?
Update of Antidiabetic Medications
Pharmacist Objectives:
1. Review the major pathophysiologic defects in Type 2
Diabetes and targeted sites for medications
2. Describe the newer antidiabetic medication classes along
with specific agents within the classes.
Technician Objectives:
Presenter
CE
Location
BERKS ROOM
Jennifer M. Belavic, PharmD,
MBA, BCPS, FASCP
1.5
FOYER
EVENT CENTER
Monroe ROOM
Richard Demers, MS, RPh, FASHP
&
Nishaminy Kasbekar, BS,
PharmD, FASHP
1
Monroe ROOM
Robert W. Rossi, RPh, CDE
1.5
Monroe ROOM
4:30pm6:00pm
6:00pm7:00pm
7:00pm8:00pm
Technicians will recognize these newer agents in the course of
carrying out their duties
Reverse Trade Show
EVENT CENTER
Cocktail Reception with Exhibits Open
EVENT CENTER
Sponsored Product Theater Dinner
Monroe Room
TOTAL
CE: 4
Time
7:00am 8:00am
8:00am 9:00am
9:00am –
10:00am
Thursday October 16, 2014
Presentation Title/Event
Novo Nordisk Sponsored Breakfast
Presenter
Scott Giberson, RPh, PhC, MPH,
DSci (H)
Rear Admiral, US Public Health
Service, Acting US Deputy
Surgeon General
Chief Professional Offer,
Pharmacy
1
EVENT
CENTER/Buck
Room
Monroe ROOM
Douglas Scheckelhoff, MS,
FASHP
1
Monroe ROOM
Deebeanne Tavani, DO, PhD
Redefining the Use of Basal Insulin: Combining Sustained Action with
QD Efficacy
Moving Beyond the Tipping Point
Pharmacist Objectives:
1. Discuss Pharmacy Report to the U.S. Surgeon General
2. Express transformative thinking based on current
health system needs and pharmacy practice
3. Explain the importance of facilitating partnerships at the
state level to help transform the profession
4. Explain a call-to-action that will improve the Nation’s health
Technician Objectives:
1. Discuss Pharmacy Report to the U.S. Surgeon General
2. Express transformative thinking based on current
health system needs and pharmacy practice
3. Explain the importance of facilitating partnerships at the
state level to help transform the profession
4. Explain a call-to-action that will improve the Nation’s health
Pharmacy Practice Advancement: How Far We’ve
Come…What’s Coming Next
Pharmacist Objectives:
1. Define practice model and how the Pharmacy Practice
Model Initiative (PPMI) can help advance practice models in
hospitals.
2. Identify key drivers of pharmacy practice change over the
past 50 years.
3. Explain how the availability of qualified pharmacy
technicians will play a pivotal role in enabling the
advancement of pharmacist practice.
4. Describe the changes in adoption of automation and
10:00am 11:30am
11:30am 12:30pm
12:30pm 1:30pm
1:30pm2:30pm
technology and how it creates new opportunities for pharmacy
5. Describe a how you can use the information presented to
evaluate and advance practice of pharmacists and technicians
in your setting practice setting
Technician Objectives:
1. Define practice model and how the Pharmacy Practice
Model Initiative (PPMI) can help advance practice models in
hospitals.
2. Identify key drivers of pharmacy practice change over the
past 50 years.
3. Explain how the availability of qualified pharmacy
technicians will play a pivotal role in enabling the
advancement of pharmacist practice
4. Describe the changes in adoption of automation and
technology and how it creates new opportunities for pharmacy.
5. Describe a how you can use the information presented to
evaluate and advance practice of pharmacists and technicians
in your setting practice setting
Exhibit Hall
EVENT CENTER
Lunch
EVENT CENTER
Considerations in Outsourcing Sterile Compounded Products
Pharmacist Objectives:
1. Demonstrate an understanding of updated regulations
regarding compounding pharmacies
2. Explain the considerations that should be evaluated
when deciding to outsource compounded products
Technician Objectives:
1. Recall the regulatory requirements necessary when
outsourcing compounded sterile products
2. Describe the quality assurance requirements of an
outsourced compounding pharmacy
Advocacy for Pennsylvania Pharmacists
Pharmacist Objectives:
1. List PSHP Advocacy Activities that have occurred
2. Describe your role in Advocacy or the legislative process
Understand the importance of advocacy to the pharmacy
community and public.
Technician Objectives:
1. List PSHP Advocacy activities
2. Describe the process of a bill
Matthew W. Eberts, PharmD,
MBA, FASHP
1
Monroe ROOM
Michele C. Musheno, MS, RPh
1
Monroe ROOM
2:30pm –
2:45pm
2:45pm –
4:45pm
3. Explain how to speak to your representative or Senator
Break
Current Topics in Hospital PharmacyPatient Safety Clinical Pearls
Medication Safety Initiatives
Pediatric Pharmacokinetic Pearls
Evaluating the Quality of Dietary Supplements
For Pain or Not for Pain: Methadone Madness
Inhaled epoprostenol: Clinical and practical considerations
Pharmacists as a Safety Measure in the Emergency Department
Standardizing Compounded Pediatric and Neonatal
Medications
Pharmacist Objectives:
1. Discuss medication safety initiatives incorporated into
practice at my institution
2. Identify barriers for implementation of safety initiatives
3. Review measures for success and data collection
for safety initiatives
4. Review pharmacokinetic differences among the pediatric age
categories.
5. Describe elements involved in pharmacogenetic influences
on pharmacodynamics.
6. Describe the potential quality problems with the current
dietary supplements on the market.
7. List examples of dietary supplement quality issues that have
been reported by the FDA in the past year.
8. Discuss the various processes that can be used to evaluate
the quality of dietary supplements.
9. Review one standard operating procedure for evaluating the
quality of a dietary supplement.
10. Describe factors that make the Emergency Department one
of the most dangerous places to receive healthcare
11. Illustrate how pharmacist presence in the ED setting can
prevent medication errors
12. Using patient case examples, demonstrate medication safety
events that can occur as a result of having multiple
compounded drug concentrations
13. Describe safety initiatives aimed at standardization of
compounded intravenous infusions and compounded oral
liquids
Technician Objectives:
Clinical Pearls
Laura Haynes, PharmD, BCPS
Jenny Boucher, BS, PharmD, JD,
BCPS
Sarah C. Erush, PharmD, BCPS
Maria Foy, PharmD, BCPS, CPE
Peter Hlavinka, PharmD, BCPS
Christopher Shaw, PharmD,
BCPS
Laura Hayn, PharmD, BCPS
2
Monroe ROOM
1. Discuss medication safety initiatives incorporated into
practice at my institution
2. Identify barriers for implementation of safety initiatives
3. Review measures for success and data collection for safety
initiatives
4. Show various parameters that are under consideration when
making dosing decisions for pediatric patients of different ages
Total
CEs: 6
5:30pm –
7:00pm
Time
7:00am –
8:00am
8:00am9:00am
9:00am 12:00pm
9:00am –
10:00am
Awards Reception
Friday October 17, 2014
Presentation Title/Event
Breakfast
Pain is Such a Pain
(1 hour of patient safety CE)
Pharmacist Objectives:
1. Review the scope of opioid related harm in hospitalized
patients
2. Review regulatory recommendations and requirements
for the appropriate use and monitoring of opioids in a
hospitalized patient
3. Review types of diversion and methods to identify
Technician Objectives:
1. Review some common look-alike sound-alike high risk errors
that can occur in hospitalized patients.
2. Review potency differences of various high-risk opioids
Student Leadership Development Workshop
The Best of Times: Pharmacy in an Era of Accountable Care
Pharmacist Objectives:
1. Describe the role of pharmacists in accountable care
organizations (ACO)
2. List four key areas to address when developing an ambulatory
care practice
3. Describe activities of a care transition pharmacist
4. List 3 resources to assist with planning pharmacy services in an
ACO
Technician Objectives:
VISION BAR
Presenter
CE
Charles J. Medico, PharmD, BCPS
1
Elaine Mebel Strauss, PharmD, MS
Toni Fera, BS, PharmD
Independent Healthcare Consultant
1
Location
EVENT
CENTER
Monroe
ROOM
Foundry
ROOM
Monroe
ROOM
10:00am
–
10:30am
10:30am11:30am
11:30am
–
12:30pm
1. Describe the role of pharmacists in accountable care
organizations (ACO)
2. Describe activities of a care transition pharmacist
3. List 3 resources to assist with planning pharmacy services in an
ACO
Break
Developments in the Treatment of Hepatitis C: A New Era
Pharmacist Objectives:
1. Summarize the results of clinical trials for the newest
medications approved for Hepatitis C treatment and where these
medications fit into treatment decisions.
2. Discuss how to develop a clinical pharmacist program for the
treatment of Hepatitis C and become an integral part of the
treatment team.
3. Apply knowledge of the medication options for Hepatitis C to
patient cases.
Technician Objectives:
1. Summarize the results of clinical trials for the newest
medications approved for Hepatitis C treatment and where these
medications fit into treatment decisions.
2. Discuss how to develop a clinical pharmacist program for the
treatment of Hepatitis C and become an integral part of the
treatment team.
3. Apply knowledge of the medication options for hepatitis C to
patient cases.
Student and Resident Integration into Innovative Collaborative
Pharmacy Practice Models
Pharmacist Objectives:
1. Discuss how inter-professional education (IPE) learning
experiences prepare graduates to develop meaningful
partnerships and add value to your institution.
2. Describe opportunities for student and resident involvement in
an interprofessional group medical visit practice model.
3. Describe resident and student involvement in the medication
reconciliation and discharge processes at an urban, teaching
medical center.
4. Identify opportunities for student and resident research
involvement associated with the medication reconciliation and
discharge processes.
5. Identify three opportunities to integrate student pharmacists
Nancy Love, PharmD, BCPS
1
Monroe
ROOM
Jane Bowen, PharmD, BCPS
Gladys Dueñas, PharmD, BCACP
Valerie Ganetsky, PharmD, BCPS
Anisha Grover, PharmD, BCACP
Karleen Melody, PharmD, BCACP
Sanchita Sen, PharmD, BCPS
1
Monroe
ROOM
and residents into a transitions of care (TOC) model that
incorporates a community hospital and pharmacy.
Technician Objectives:
1. Discuss how interprofessional education (IPE) learning
experiences prepare graduates to develop meaningful
partnerships and add value to your institution.
2. Describe opportunities for student and resident involvement in
an interprofessional group medical visit practice model.
3. Describe resident and student involvement in the medication
reconciliation and discharge processes at an urban, teaching
medical center.
4. Identify opportunities for student and resident research
involvement associated with the medication reconciliation and
discharge processes.
5. Identify three opportunities to integrate student pharmacists
and residents into a transitions of care (TOC) model that
incorporates a community hospital and pharmacy.
TOTAL
CEs: 4
Total CEs if you attend the full conference: 14